Discovering why young people are prone to certain kinds of cancer, relative to adults, reveals important insights about cancer that can benefit both groups. The fast-developing cells in a growing body differs from the development of cancer. Patricia Ernst, PhD,...

When Arushi Raval was 12, her childhood friend, Kuhu Basak, was diagnosed with brain cancer. Surgeons were able to remove 30 percent of Basak’s tumor. This was followed by six weeks of proton radiation therapy, but the tumor grew back. She has gone through multiple...

University of Colorado Cancer Center physician/scientists are among those receiving funding for innovative, groundbreaking projects to advance clinical care for kids with cancer. In its summer grants cycle, the St. Baldrick’s Foundation awarded dozens of grants...

In 2002, the FDA approved the drug imatinib as a first-line therapy for adults with chronic myeloid leukemia (CML) caused by the fusion gene BCR-ABL, known as the Philadelphia chromosome. The approval dramatically extended the lives of patients with the condition and,...

Treatments for childhood cancers have improved to the point that 5-year survival rates are over 80 percent. However, one group has failed to benefit from these improvements, namely children who die so soon after diagnosis that they are not able to receive treatment,...